Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TKTX
Not explicitly listed; likely China-based manufacturer with global distribution via e-commerce platforms.[7]
- Ownership
- Private
- Development stage
- Other
01
Overview
TKTX produces topical numbing creams and gels primarily for use in cosmetic procedures to reduce pain. Their products contain high concentrations of anesthetic agents like lidocaine. The FDA has issued a warning letter to the company regarding unapproved drug status and safety concerns due to excessive lidocaine content exceeding over-the-counter limits; these products may pose health risks if misused or applied on large/broken skin areas
- Therapeutic areas
- Dermatology
- Modalities
- Topical anesthetics (creams, gels, sprays) containing lidocaine and related agents
- Industry
- Biotech
02
Partnerships
No major pharmaceutical or biotech partnerships reported; operates mainly as an independent consumer health brand.
Beyond the preview
Go deeper on TKTX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TKTX.